12 news items
Kevzara® (sarilumab) Approved by FDA for the Treatment of Active Polyarticular Juvenile Idiopathic Arthritis (pJIA)
REGN
11 Jun 24
are an innovative global healthcare company, driven by one purpose: we chase the miracles of science to improve
MAIA Biotechnology Inc (MAIA) Stock Surges as Company Prepares to Present Promising Data at BIO International Convention
CRL
IQV
MAIA
31 May 24
is for informational purposes only and does not constitute financial advice or an endorsement of MAIA or its strategies. FOR EDUCATIONAL AND INFORMATION PURPOSES
Press Release: Dupixent recommended for EU approval by the CHMP to treat patients with COPD
REGN
31 May 24
or X. About SanofiWe are an innovative global healthcare company, driven by one purpose: we chase
Dupixent® (dupilumab) Recommended for EU Approval by the CHMP to Treat Patients with COPD
REGN
31 May 24
are an innovative global healthcare company, driven by one purpose: we chase the miracles of science to improve people's lives. Our team, across
Update on FDA Priority Review of Dupixent® (dupilumab) for the Treatment of COPD Patients with Type 2 Inflammation
REGN
31 May 24
by one purpose: we chase the miracles of science to improve people's lives. Our team, across some 100 countries, is dedicated to transforming
kpz4v2a2vtz684v1
REGN
31 May 24
global healthcare company, driven by one purpose: we chase the miracles of science to improve people's lives. Our team, across some 100 countries
083uqsabfd4fr2p1b7ga0i77shqla1momdgeukr
REGN
20 May 24
are an innovative global healthcare company, driven by one purpose: we chase the miracles of science to improve people's lives. Our team, across the world
69yqmmjz6nbuz80d9t3n61p2tfjdqts8mls2hb40okrortgfduyxn51
REGN
20 May 24
global healthcare company, driven by one purpose: we chase
nfhojhvydgkydgxbdgq mkg30pgfo
REGN
13 May 24
global healthcare company, driven by one purpose: we chase the miracles of science to improve people's lives
7huo2ebc9hregmylbophr ltb5bw
ARGX
ATNM
MRNA
28 Mar 24
-announces-clinical-trial-study-111800504.html
Disclaimer: This blog post is for informational purposes only and does
wu8yc60zs503rypfeec0l6s4qmts51skid63130r5e9h
ARGX
ATNM
AZN
26 Mar 24
.
Disclaimer: This blog post is for informational purposes only and does not constitute financial advice or an endorsement of ATNM
o28yzpnpjnq87gfgw4ech9hpfq171r6iwkjjwb9 zh
ARGX
ATNM
AZN
22 Mar 24
: This blog post is for informational purposes only and does not constitute financial advice or an endorsement of ATNM or its strategies. FOR EDUCATIONAL
- Prev
- 1
- Next